[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fgDkKRMZmalFxi1camAgCfy5tPFT45YkDLXjOCf00Qxg":3,"$f221WBGhX8SM1A3gnFuR1vPRazELjgrStL346Wj4rflQ":115},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},3514,"axicorp-pharma-b-v","axicorp Pharma GmbH",null,"NLD","ted-v3","https://ted.europa.eu/de/notice/-/detail/367392-2026","2026-06-11 06:06:45","2026-07-20 02:00:54",9,0,"2026-07-08T00:00:00.000Z",[18,38,49,56,65,75,84,94,105],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":33,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},480960,151181,"469114-2026","https://ted.europa.eu/de/notice/-/detail/469114-2026","can-standard","2025-08-01T00:00:00.000Z","LOT-0001","Nilotinib (ausgenommen als Dispersion in Apfelmus), ATC L01EA03","axicorp Pharma B.V.","HRB 7637","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)","DAK-Gesundheit","DE","33600000","2026-07-07T22:00:00.000Z",{"award_id":39,"tender_id":40,"source_name":10,"source_award_id":41,"source_url":42,"award_notice_type":23,"award_date":43,"publication_date":44,"lot_number":25,"contract_title":45,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":46,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},479770,149948,"459153-2026","https://ted.europa.eu/de/notice/-/detail/459153-2026","2024-07-01T00:00:00.000Z","2026-07-03T00:00:00.000Z","Etravirin, ATC J05AG04","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2024 - 30.06.2026","DE-HH","2026-07-02T22:00:00.000Z",{"award_id":50,"tender_id":51,"source_name":10,"source_award_id":52,"source_url":53,"award_notice_type":23,"award_date":43,"publication_date":44,"lot_number":25,"contract_title":54,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":55,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":48,"tender_deadline_utc":8},479823,153042,"460579-2026","https://ted.europa.eu/de/notice/-/detail/460579-2026","Dornase alfa, ATC R05CB13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2024 - 30.06.2026",{"award_id":57,"tender_id":58,"source_name":10,"source_award_id":59,"source_url":60,"award_notice_type":23,"award_date":61,"publication_date":62,"lot_number":25,"contract_title":63,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":64,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":37,"tender_deadline_utc":8},474736,151178,"431583-2026","https://ted.europa.eu/de/notice/-/detail/431583-2026","2024-04-01T00:00:00.000Z","2026-06-24T00:00:00.000Z","Rivaroxaban, ATC B01AF01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":66,"tender_id":67,"source_name":10,"source_award_id":68,"source_url":69,"award_notice_type":23,"award_date":70,"publication_date":71,"lot_number":25,"contract_title":72,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":73,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":74,"tender_deadline_utc":8},469271,144005,"413359-2026","https://ted.europa.eu/de/notice/-/detail/413359-2026","2025-03-01T00:00:00.000Z","2026-06-16T00:00:00.000Z","Pegfilgrastim, ATC L03AA13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)","2026-06-15T22:00:00.000Z",{"award_id":76,"tender_id":77,"source_name":10,"source_award_id":78,"source_url":11,"award_notice_type":23,"award_date":79,"publication_date":80,"lot_number":25,"contract_title":81,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":82,"buyer_name":34,"region_code":47,"cpv_code":36,"tender_published_at_utc":83,"tender_deadline_utc":8},379986,24791,"367392-2026","2024-06-01T00:00:00.000Z","2026-05-29T00:00:00.000Z","Bexaroten, ATC L01XF03","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2024 - 31.05.2026","2026-05-28T22:00:00.000Z",{"award_id":85,"tender_id":86,"source_name":10,"source_award_id":87,"source_url":88,"award_notice_type":23,"award_date":89,"publication_date":90,"lot_number":25,"contract_title":91,"winner_name":27,"winner_identifier":28,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":92,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":93,"tender_deadline_utc":8},369042,26906,"309964-2026","https://ted.europa.eu/de/notice/-/detail/309964-2026","2024-05-01T00:00:00.000Z","2026-05-06T00:00:00.000Z","Sofosbuvir und Velpatasvir , ATC J05AP55","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Sofosbuvir und Velpatasvir, ATC J05AP55 für die Zeit 01.05.2024 - 30.04.2026","2026-05-05T22:00:00.000Z",{"award_id":95,"tender_id":96,"source_name":10,"source_award_id":97,"source_url":98,"award_notice_type":23,"award_date":99,"publication_date":100,"lot_number":25,"contract_title":101,"winner_name":7,"winner_identifier":28,"winner_country":102,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":103,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":104,"tender_deadline_utc":8},363917,42393,"26169-2026","https://ted.europa.eu/de/notice/-/detail/26169-2026","2024-01-01T00:00:00.000Z","2026-01-14T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsform DOS), ATC R03AK08","DEU","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-13T23:00:00.000Z",{"award_id":106,"tender_id":107,"source_name":10,"source_award_id":108,"source_url":109,"award_notice_type":23,"award_date":99,"publication_date":110,"lot_number":25,"contract_title":111,"winner_name":27,"winner_identifier":112,"winner_country":9,"value_eur":8,"currency":29,"confidence":30,"visibility":31,"access_tier":32,"company_slug":6,"company_name":7,"website_url":8,"tender_title":113,"buyer_name":34,"region_code":35,"cpv_code":36,"tender_published_at_utc":114,"tender_deadline_utc":8},358123,42515,"21340-2026","https://ted.europa.eu/de/notice/-/detail/21340-2026","2026-01-13T00:00:00.000Z","Buserelin, ATC L02AE01","53464923","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Buserelin, ATC L02AE01 für die Zeit 01.01.2024 - 31.12.2025","2026-01-12T23:00:00.000Z",{"company_slug":6,"years":116,"award_count":14,"top_buyers":117,"yearly_trend":121},5,[118],{"buyer_name":34,"buyer_key":119,"award_count":14,"total_value_eur":15,"share_count":120},"dak-gesundheit",1,[122],{"year":123,"award_count":14},2026]